Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Towards Onset Prevention of Cognitive Decline in Adults with Down Syndrome (TOP-COG)
2011-001564-21Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) and Down syndrome comparing Simvastatin with Placebo (2 arms). Primary endpoint: Feasibility. Started Aug 2011; status: completed.
02
Drugs
simvastatin
03
Conditions
Alzheimer's disease (AD)Down syndrome
Beyond the preview
Go deeper on 2011-001564-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001564-21.